Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

The Molecular Anatomy of Neurons

NeuroMolAnatomy

The brain is nowadays the object of a number of extensive systematic studies that focus on seemingly all aspects of its morphology and function, from overall brain architecture to neuronal connections, neuronal morphology and gene expression. However, at least one basic aspect is as yet incompletely studied: the molecular anatomy of the neuron, i.e...

Funding Programme
Start Date
End Date
Total Funding
€ 1 985 063
European Countries Involved

The role of DREAM in synaptic dysfunction in Alzheimer's disease

DREAM IN AD

Alzheimer's disease (AD) is the most common form of age-related dementia. This neurodegenerative disorder is characterized by massive neuronal death and deposition of amyloid-β peptide (Aβ), which is formed by processing of amyloid precursor protein (APP). The mechanism of neuronal degeneration in AD are not well understood, but growing evidence...

Funding Programme
Start Date
End Date
Total Funding
€ 60 417
European Countries Involved

The Role of Non-coding RNA in Protein Networks and Neurodegenerative Diseases

RIBOMYLOME

'A major portion of the eukaryotic genome is occupied by DNA sequences whose transcripts do not code for proteins. This part of the genome is transcribed in a developmentally regulated manner and in response to external stimuli to produce large numbers of long non-coding RNAs (lncRNAs). From the beginning of transcription through splicing and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 465 351
European Countries Involved

The role of the voltage-gated potassium channels and their modulators in mechanisms of plasticity underlying learning and memory in Drosophila

KV CHANNELS & MEMORY

Voltage-gated potassium (Kv) channel are neuronal and allow the temporal encoding of information as spike trains in neural circuits. It is therefore important to investigate how each Kv channel is able to do this so that we can better understand how brains work and generate plastic behaviour. In addition genetic diseases (channelopathies)...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

The structural and dynamical ensemble of an amyloidogenic intermediate

AMYLOIDINTERMEDIATE

Proteins and peptides have a generic tendency to convert from their soluble states into well-organized aggregates characterized by a fibrillar morphology and an extended cross-beta structure. Such transitions can give rise to over 40 pathological conditions ranging from neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease...

Funding Programme
Start Date
End Date
Total Funding
€ 171 868
European Countries Involved

The zebrafish as a new vertebrate model for molecular and cellular mechanisms of learning and memory, including synaptic dysfunction in Alzheimer's disease

LEARNING AND MEMORY

A majority of our most common neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, age-related dementia and multiple sclerosis, are manifested by memory loss and a reduced potential for learning. Additionally, a substantial portion of our population suffers from various forms of learning difficulties. Despite all the efforts to...

Funding Programme
Start Date
End Date
Total Funding
€ 231 852
European Countries Involved

THERAPEUTIC AND PREVENTIVE IMPACT OF NUTRITIONAL LIPIDS ON NEURONAL AND COGNITIVE PERFORMANCE IN AGING, ALZHEIMER’S DISEASE AND VASCULAR DEMENTIA

LIPIDIDIET

Major objective: It is our aim to develop a lipid based diet that is able to delay or prevent onset of Alzheimer’s disease and related diseases and has a stabilizing effect on cognitive performance in aging. Multiple lines of evidence suggest that there is a large overlap between risk factor of these three diseases. Importantly, there is equally...

Funding Programme
Start Date
End Date
Total Funding
€ 7 995 577
European Countries Involved

Time and experience dependent evolution of hippocampal memory codes

MemoryCodes

Following initial learning, information stored in memory undergoes a time- and experience-dependent evolution. Currently, the nature of this evolution at the neuronal ensemble level remains largely unknown. To obtain insight into this dynamic process there is a need to follow memory-associated neuronal representations in large populations of single...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Tracking accumulation processes in memory decisions

ACCDECMEM

Every day we need to remember whether we have seen people before and adjust our decisions accordingly. The goal of the proposed research is to further our understanding of decisions based on remembered information by following those as they happen in the brain. To be able to study neural decision dynamics, we use computational models of recognition...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

UNDERSTANDING THE CAUSES OF THE RNA GAIN OF FUNCTION DISEASES

RNA DISEASES

It is now increasingly clear that most of our genome is transcribed, but that only a small portion is associated with protein coding gene. Indeed, recent analysis indicate that long non-coding RNA outnumbered by five fold the coding RNA sequences. Despite this abundance, very little is known on the function of these long non-coding RNA. The aim of...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 920
European Countries Involved

Vascular and Aymloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects

VASCAMY

Alzheimer’s disease (AD) is the most frequent cause of dementia that affects one in 14 persons over the age 65 years and one in six persons over the age of 80 years. Increased deposition of the protein beta-amyloid (Aß) is a core brain pathology of AD that occurs years before the onset of clinical symptoms of dementia. Together with Aß...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Vascular Dementia: revealing the detrimental synergy between hypertension, micro-strokes and Neuro-Vascular Decoupling"

VD&NVD

Research in recent years has started to provide an alternative view to Alzheimer's etiology emphasizing the role of other factors such as inflammation and brain vascular alterations in the development of Alzheimer. Of major interest is the link between AD and hypertension, another global epidemic affecting millions of people worldwide. Hypertension...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).